PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 281 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 6.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $17,347,361 | -22.6% | 565,429 | +1.1% | 4.35% | -6.7% |
Q2 2023 | $22,407,504 | -2.3% | 559,209 | -0.4% | 4.66% | -3.3% |
Q1 2023 | $22,923,385 | +5.4% | 561,710 | -0.3% | 4.82% | +0.3% |
Q4 2022 | $21,753,453 | -28.8% | 563,415 | -1.9% | 4.80% | -28.5% |
Q3 2022 | $30,563,000 | -11.8% | 574,608 | -3.3% | 6.72% | -7.5% |
Q2 2022 | $34,653,000 | -25.7% | 594,392 | -2.7% | 7.26% | -4.5% |
Q1 2022 | $46,626,000 | +26.2% | 610,933 | -0.5% | 7.60% | +37.3% |
Q4 2021 | $36,932,000 | +15.6% | 613,790 | +7.6% | 5.54% | +16.7% |
Q3 2021 | $31,956,000 | +5.5% | 570,643 | +14.3% | 4.75% | +10.4% |
Q2 2021 | $30,300,000 | -5.0% | 499,333 | +9.8% | 4.30% | -11.4% |
Q1 2021 | $31,880,000 | +22.5% | 454,849 | +4.6% | 4.86% | +17.2% |
Q4 2020 | $26,028,000 | +1.7% | 434,955 | +2.2% | 4.14% | -24.1% |
Q3 2020 | $25,591,000 | +15.5% | 425,667 | +0.8% | 5.46% | +1.7% |
Q2 2020 | $22,150,000 | +62.2% | 422,141 | +3.7% | 5.36% | +15.7% |
Q1 2020 | $13,652,000 | -21.9% | 407,159 | +5.5% | 4.64% | +21.2% |
Q4 2019 | $17,482,000 | +18.5% | 385,912 | -0.4% | 3.83% | +9.6% |
Q3 2019 | $14,748,000 | +21.7% | 387,379 | +39.0% | 3.49% | +33.6% |
Q2 2019 | $12,117,000 | – | 278,613 | – | 2.61% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |